The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer …
M Ducreux, GK Abou-Alfa, T Bekaii-Saab, J Berlin… - ESMO open, 2023 - Elsevier
Highlights•The incidence of HCC will continue to rise.•HCC is curable at an early
stage.•New locoregional treatments such as radioembolisation are showing impressive …
stage.•New locoregional treatments such as radioembolisation are showing impressive …
Stereotactic magnetic resonance-guided adaptive and non-adaptive radiotherapy on combination MR-linear accelerators: current practice and future directions
JM Bryant, J Weygand, E Keit, R Cruz-Chamorro… - Cancers, 2023 - mdpi.com
Simple Summary Stereotactic body radiotherapy (SBRT) is an effective radiation therapy
technique that heavily relies upon daily image guidance to achieve the necessary precision …
technique that heavily relies upon daily image guidance to achieve the necessary precision …
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience …
K Su, F Wang, X Li, H Chi, J Zhang, K He… - Frontiers in …, 2023 - frontiersin.org
Background The optimal local treatment for HCC with tumor diameter≥ 5 cm is not well
established. This research evaluated the effectiveness of external beam radiation therapy …
established. This research evaluated the effectiveness of external beam radiation therapy …
[HTML][HTML] Proton beam therapy for hepatocellular carcinoma: Multicenter prospective registry study in Japan
M Mizumoto, H Ogino, T Okumura, K Terashima… - International Journal of …, 2024 - Elsevier
Purpose A prospective multicenter registry study was started May 2016 in Japan to evaluate
the efficacy and safety of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) …
the efficacy and safety of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) …
The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms
H Jiang, J Liao, L Wang, C Jin, J Mo… - Frontiers in …, 2023 - frontiersin.org
Advanced hepatocellular carcinoma (HCC) is a formidable public health problem with
limited curable treatment options. Axitinib, an oral tyrosine kinase inhibitor, is a potent and …
limited curable treatment options. Axitinib, an oral tyrosine kinase inhibitor, is a potent and …
Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions–A Systematic Review and Network Meta-analysis
LQ Li, TS Su, QY Wu, ZT Lin, SX Liang - Clinical Oncology, 2023 - Elsevier
Surgical resection, stereotactic body radiotherapy (SBRT) and radiofrequency ablation
(RFA) have seldom been compared for small hepatocellular carcinoma (HCC). We explored …
(RFA) have seldom been compared for small hepatocellular carcinoma (HCC). We explored …
Local treatment of hepatocellular carcinoma with oligometastases: a systematic Review and meta-analysis
S Kim, J Lee, CH Rim - Cancers, 2023 - mdpi.com
Simple Summary Oligometastasis is defined as a malignancy disease characterized by a
limited number of metastatic foci (3–5). In studies of lung cancer and prostate cancer, local …
limited number of metastatic foci (3–5). In studies of lung cancer and prostate cancer, local …
Oligometastasis: Expansion of Curative Treatments in the Field of Oncology
AR Lim, CH Rim - Medicina, 2023 - mdpi.com
Oligometastasis is defined as the presence of several limited metastatic lesions and is
generally limited to three or fewer than five metastatic lesions. Previously, the treatment of …
generally limited to three or fewer than five metastatic lesions. Previously, the treatment of …
Do We Have a Winner? Advocating for SBRT in HCC Management
AH Safavi, LA Dawson, A Mesci - Clinical and Translational Radiation …, 2024 - ctro.science
2 a LC rate of 100% at 1 and 2 years, which was more than double the LC rate of TACE (p=
0.019). The worse LC of TACE may be attributable to treatment-induced damage to …
0.019). The worse LC of TACE may be attributable to treatment-induced damage to …
[HTML][HTML] S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome “–Kurzversion
M Bitzer, S Groß, J Albert, S Blödt… - Zeitschrift für …, 2024 - thieme-connect.com
Thieme E-Journals - Zeitschrift für Gastroenterologie / Full Text DE EN Home Products Journals
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …